Alterity Therapeutics Statistics
Total Valuation
ATHE has a market cap or net worth of $91.69 million. The enterprise value is $57.19 million.
| Market Cap | 91.69M |
| Enterprise Value | 57.19M |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATHE has 217.51 million shares outstanding. The number of shares has increased by 74.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 217.51M |
| Shares Change (YoY) | +74.72% |
| Shares Change (QoQ) | +36.08% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 34.56% |
| Float | 166.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.71 |
| Forward PS | 24.63 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 21.98 |
| Quick Ratio | 21.68 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.02% and return on invested capital (ROIC) is -35.26%.
| Return on Equity (ROE) | -47.02% |
| Return on Assets (ROA) | -32.54% |
| Return on Invested Capital (ROIC) | -35.26% |
| Return on Capital Employed (ROCE) | -32.33% |
| Weighted Average Cost of Capital (WACC) | 4.19% |
| Revenue Per Employee | $491,849 |
| Profits Per Employee | -$1.08M |
| Employee Count | 9 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATHE has paid $86,461 in taxes.
| Income Tax | 86,461 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.70% in the last 52 weeks. The beta is -0.01, so ATHE's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +12.70% |
| 50-Day Moving Average | 4.33 |
| 200-Day Moving Average | 3.89 |
| Relative Strength Index (RSI) | 63.81 |
| Average Volume (20 Days) | 102,883 |
Short Selling Information
The latest short interest is 9,216, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 9,216 |
| Short Previous Month | 8,051 |
| Short % of Shares Out | 0.05% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, ATHE had revenue of $4.43 million and -$9.73 million in losses. Loss per share was -$0.06.
| Revenue | 4.43M |
| Gross Profit | 4.32M |
| Operating Income | -11.72M |
| Pretax Income | -9.65M |
| Net Income | -9.73M |
| EBITDA | -11.71M |
| EBIT | -11.72M |
| Loss Per Share | -$0.06 |
Balance Sheet
The company has $32.82 million in cash and $65,668 in debt, with a net cash position of $32.75 million or $0.15 per share.
| Cash & Cash Equivalents | 32.82M |
| Total Debt | 65,668 |
| Net Cash | 32.75M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 36.20M |
| Book Value Per Share | 0.17 |
| Working Capital | 36.18M |
Cash Flow
| Operating Cash Flow | -9.15M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 9,516 |
| Net Borrowing | -87,726 |
| Free Cash Flow | -9.62M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 97.55%, with operating and profit margins of -264.66% and -219.85%.
| Gross Margin | 97.55% |
| Operating Margin | -264.66% |
| Pretax Margin | -217.90% |
| Profit Margin | -219.85% |
| EBITDA Margin | -264.46% |
| EBIT Margin | -264.66% |
| FCF Margin | n/a |
Dividends & Yields
ATHE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.72% |
| Shareholder Yield | -74.72% |
| Earnings Yield | -10.61% |
| FCF Yield | -10.49% |
Analyst Forecast
The average price target for ATHE is $11.00, which is 125.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 125.41% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -15.56% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 9, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ATHE has an Altman Z-Score of 15.68 and a Piotroski F-Score of 3.
| Altman Z-Score | 15.68 |
| Piotroski F-Score | 3 |